Tirofiban is an antiplatelet medication used to prevent blood clots in people with coronary artery disease. It is also known as an anti-thrombotic, anticoagulant or platelet aggregation inhibitor. Tirofiban works by blocking the action of platelet aggregation and reducing the risk of blood clots forming in the arteries. It is usually administered as an intravenous injection, and the effects usually last up to 24 hours. Tirofiban is sometimes used in conjunction with other antiplatelet medications, such as aspirin or clopidogrel, to further reduce the risk of clot formation. Side effects of tirofiban include nausea, dizziness, headache, and abdominal pain.
Tirofiban, sold under the brand name Aggrastat, is a medication used to prevent blood clots during episodes of chest pain or a heart attack, or while undergoing a procedure to treat a blocked coronary artery. It belongs to a class of medications called glycoprotein IIb/IIIa inhibitors.
Tirofiban works by preventing platelets in the blood from sticking together and forming clots. This can help to reduce the risk of a heart attack or stroke. Tirofiban is given as an injection into a vein by a healthcare professional.